Endo Health Solutions, Inc. (NASDAQ:ENDP)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.


Player Avatar cajun1958 (27.12) Submitted: 3/20/2014 3:48:33 PM : Underperform Start Price: $72.98 ENDP Score: +10.12

Lack of anything new can be a problem in pharma when patents expire. ENDO is attempting to grow by acquisition but that rarely works especially when your competitors are after the same thing.

Featured Broker Partners